In order to test the effect of nucleolin and Ras inhibition on tumor cell growth, we used two inhibitors: FTS (salirasib) [29-31], a powerful Ras inhibitor, and GroA (AS1411), an aptamer that targets cell surface nucleolin [16,32-34]. This evidence concerns the gene CXCL1 and neoplasm.